Ubs Asset Management Americas Inc Xeris Biopharma Holdings, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 37,619 shares of XERS stock, worth $315,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,619Holding current value
$315,247% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
207Shares Held
89.4MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$86.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$82.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$32.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$31.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$30.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.14B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...